Quarterly report [Sections 13 or 15(d)]

SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)

v3.26.1
SCHEDULE OF STOCK OPTIONS ACTIVITY (Details) - USD ($)
 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Equity [Abstract]    
Number of Shares, Outstanding, beginning balance 796,660 1,605,060
Weighted Average Exercise Price, Outstanding, beginning balance $ 4.10 $ 4.85
Weighted Average Grant Date Fair Value, beginning balance $ 3.08  
Number of Shares, Granted 536,239
Weighted Average Exercise Price, Granted $ 1.88  
Weighted Average Grant Date Fair Value, Granted $ 1.23  
Number of Shares, Exercised (62,125)
Weighted Average Exercise Price, Exercised $ 4.10  
Weighted Average Grant Date Fair Value, Exercised $ 3.40  
Number of Shares, Forfeited and cancelled (304,440) (387,535)
Weighted Average Exercise Price, Forfeited and cancelled $ 3.43 $ 3.39
Aggregate intrinsic Value, Exercised $ 115,095  
Weighted Average Grant Date Fair Value, Forfeited and cancelled $ 2.54  
Number of Shares, Outstanding, ending balance 966,334 1,217,525
Weighted Average Exercise Price, Outstanding, ending balance $ 3.08 $ 5.32
Weighted Average Remaining Contract Term (years), Outstanding 6 years 9 months 5 years 4 months 2 days
Weighted Average Grant Date Fair Value, ending balance $ 2.21  
Number of Shares, Exercisable, ending balance 729,335 766,905
Weighted Average Exercise Price, Exercisable, ending balance $ 3.47 $ 6.39
Weighted Average Remaining Contract Term (years), exercisable 6 years 2 months 23 days 3 years 7 months 6 days
Weighted Average Grant Date Fair Value, Exercisable $ 2.52